Article By:
Zacks Investment Research
Saturday, March 9, 2024 4:00 PM EDT
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the year.
Exact Sciences: Poised For Further Growth
Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS
Exact Sciences: Poised For Further Growth
Article is a good summary and is likely representative of the future for $EXAS.